Showing results (1-10 of 1,014) with videos related to
Sort By:
Pageof 102
Expert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonMolecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonCancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancersPaul G Richardson, Teru Hideshima, Kenneth C AndersonReviews in Clinical and Experimental Hematology|February 7, 2004
Targeting proteasome inhibition in hematologic malignanciesTeru Hideshima, Paul G Richardson, Kenneth C AndersonCell Cycle (Georgetown, Tex.)|January 19, 2005
Proteasome inhibition in the treatment of cancerPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.British Journal of Haematology|January 18, 2006
Novel therapeutic strategies targeting growth factor signalling cascades in multiple myelomaHiroshi Yasui, Teru Hideshima, Paul G Richardson, et al.Annual Review of Medicine|January 18, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.Current Pharmaceutical Biotechnology|November 2, 2006
Recent advances in the treatment of Multiple MyelomaHiroshi Yasui, Teru Hideshima, Paul G Richardson, et al.Oncology (Williston Park, N.Y.)|March 2, 2006
New treatments for multiple myelomaPaul G Richardson, Robert Schlossman, Teru Hideshima, et al.Therapeutics and Clinical Risk Management|August 30, 2008
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myelomaTeru Hideshima, Noopur Raje, Paul G Richardson, et al.Pageof 102